Morten Persson

Title: Morten Persson: Innovator in Medical Imaging

Introduction

Morten Persson is a notable inventor based in Copenhagen, Denmark. He has made significant contributions to the field of medical imaging, particularly in the development of innovative techniques for cancer diagnosis and treatment monitoring. With a total of 5 patents to his name, Persson's work is at the forefront of medical technology.

Latest Patents

One of Morten Persson's latest patents involves the creation of positron-emitting radionuclide labeled peptides for human uPAR PET imaging. This invention provides a non-invasive method for imaging the Urokinase-type Plasminogen Activator Receptor (uPAR) in humans. Specifically, it relates to human uPAR PET imaging of any solid cancer disease, aiding in diagnosis, staging, treatment monitoring, and serving as an imaging biomarker for predicting prognosis, progression, and recurrence.

Career Highlights

Throughout his career, Morten Persson has worked with various companies, including Curasight A/S and Curasight ApS. His innovative approaches have positioned him as a key figure in the medical imaging sector, contributing to advancements that enhance patient care and treatment outcomes.

Collaborations

Morten has collaborated with notable professionals in his field, including Andreas Kjaer and Jacob Madsen. These partnerships have further enriched his work and expanded the impact of his inventions.

Conclusion

Morten Persson's contributions to medical imaging through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in cancer diagnosis and treatment, ultimately benefiting patients worldwide.